Table 1.
Ref. | Year | Description | Donor type | n | Survival |
Yao et al[13] | 2001 | 1 lesion ≤ 6.5 cm, or 2-3 lesions ≤ 4.5 cm each. Total tumor diameter ≤ 8 cm | Cadaveric | 70 | 5 yr OS: 72.4% |
Herrero et al[16] | 2001 | 1 lesion ≤ 6 cm, or 2-3 lesions ≤ 5 cm each | Cadaveric | 47 | 5 yr OS: 79% |
Roayaie et al[19] | 2002 | Any number of lesions, 5-7 cm each | Cadaveric | 43 | 5 yr RFS: 55% |
Keneteman et al[20] | 2004 | 1 lesion < 7.5 cm, or multiple lesions < 5 cm each | Cadaveric | 40 | 4 yr OS: 82.9% |
4 yr RFS: 76.8% | |||||
Onaca et al[18] | 2007 | 1 lesion ≤ 6 cm, or 2-4 lesions ≤ 5 cm each | Cadaveric | 1206 | 5 yr RFS: 1 lesion ≤ 6 cm: 63.9%/or 2-4 lesions 3.1 cm-5 cm each: 64.6% |
Soejima et al[23] | 2007 | Any number lesions ≤ 5 cm each | Living | 67 | 3 yr OS: 68.6% |
Jonas et al[24] | 2007 | Single lesion and diameter, or any number of lesions ≤ 6 cm each. Total tumor diameter ≤ 15 cm | Living | 21 | 3 yr OS: 53% |
Sugawara et al[25] | 2007 | Up to 5 lesions ≤ 5 cm each | Living | 78 | 3 yr RFS: 94% |
Silva et al[17] | 2008 | 1-3 lesions ≤ 5 cm each. Total tumor diameter ≤ 10 cm | Cadaveric | 257 | 5 yr OS: 67% |
Mazzaferro et al[21] | 2009 | The sum of the size and number of tumors not exceeding 7 in the absence of microvascular invasion | Both | 1556 | 5 yr OS: 71.2% |
RFS: Recurrence free survival; OS: Overall survival.